Abstract
Despite the use of statin therapy, a significant proportion of patients with coronary artery disease (CAD) still develop cardiovascular events. We hypothesized that development of mitochondrial dysfunction (MD) after statin therapy might be linked to endothelial dysfunction and thus limiting its beneficial effects. We studied the effect of MD on endothelial function in 119 patients with CAD on long-term statins (>1 year). Brachial artery flow-mediated dilation (FMD) was assessed by high-resolution ultrasonography and blood levels of lactate, pyruvate, fasting glucose, and lipids were measured. MD (defined by a lactate/pyruvate ratio >75th percentile of the age- and sex-matched normal controls, i.e., ≥18) was observed in 43/119(36%) patients. There were no significant differences in age, gender, and clinical characteristics between patients with or without MD (all P > 0.05). Patients with MD received higher dose of statin (23.5 ± 19.3 vs. 17.1 ± 10.5 mg simvastatin-equivalent dose, P = 0.05) and had lower FMD (2.69 ± 2.94 vs. 4.33 ± 2.80%, P = 0.003) than those without MD. Multivariate analysis showed that statin dosage was independently associated with MD (OR:1.03, P = 0.03), and MD significantly predicted an absolute 1.36% decrease in FMD (P = 0.01). In conclusion, a significant proportion of patients with CAD on statin developed MD, which was associated with high-dose statin and with impaired FMD, suggesting that increased statin dosage may induce MD and contribute to endothelial dysfunction in patients with CAD.
Similar content being viewed by others
References
LaRosa, J. C., He, J., & Vupputuri, S. (1999). Effect of statins on risk of coronary disease: A meta-analysis of randomized controlled trials. JAMA, 282, 2340–2346.
Nissen, S. E., Tuzcu, E. M., Schoenhagen, P., Crowe, T., Sasiela, W. J., Tsai, J., et al. (2005). Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease. New England Journal of Medicine, 352, 29–38.
Langsjoen, P. H., & Langsjoen, A. M. (2003). The clinical use of HMG CoA-reductase inhibitors and the associated depletion of coenzyme Q10. A review of animal and human publications. Biofactors, 18, 101–111.
Thompson, P. D., Clarkson, P., & Karas, R. H. (2003). Statin-associated myopathy. JAMA, 289, 1681–1690.
Phillips, P. S., Haas, R. H., Bannykh, S., Hathaway, S., Gray, N. L., Kimura, B. J., et al. (2002). Statin-associated myopathy with normal creatine kinase levels. Annals of Internal Medicine, 137, 581–585.
Chariot, P., Monnet, I., Mouchet, M., Rohr, M., Lefaucheur, J. P., Dubreuil-Lemaire, M. L., et al. (1994). Determination of the blood lactate:pyruvate ratio as a noninvasive test for the diagnosis of zidovudine myopathy. Arthritis and Rheumatism, 37, 583–586.
Munnich, A., Rotig, A., Chretien, D., Saudubray, J. M., Cormier, V., & Rustin, P. (1996). Clinical presentations and laboratory investigations in respiratory chain deficiency. European Journal of Pediatrics, 155, 262–274.
De Pinieux, G., Chariot, P., Ammi-Said, M., Louarn, F., Lejonc, J. L., Astier, A., et al. (1996). Lipid-lowering drugs and mitochondrial function: Effects of HMG-CoA reductase inhibitors on serum ubiquinone and blood lactate/pyruvate ratio. British Journal of Clinical Pharmacology, 42, 333–337.
Heart Protection Study Collaborative Group. (2002). MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: A randomised placebo-controlled trial. Lancet, 360, 7–22.
Madamanchi, N. R., & Runge, M. S. (2007). Mitochondrial dysfunction in atherosclerosis. Circulation Research, 100, 460–473.
Puddu, P., Puddu, G. M., Galletti, L., Cravero, E., & Muscari, A. (2005). Mitochondrial dysfunction as an initiating event in atherogenesis: A plausible hypothesis. Cardiology, 103, 137–141.
Lerman, A., & Zeiher, A. M. (2005). Endothelial function: Cardiac events. Circulation, 111, 363–368.
Chan, Y. H., Lau, K. K., Yiu, K. H., Li, S. W., Chan, H. T., Tam, S., et al. (2007). Isoflavone intake in persons at high risk of cardiovascular events: Implications for vascular endothelial function and the carotid atherosclerotic burden. American Journal of Clinical Nutrition, 86, 938–945.
Lau, K. K., Chan, Y. H., Yiu, K. H., Li, S. W., Tam, S., Lau, C. P., et al. (2007). Burden of carotid atherosclerosis in patients with stroke: Relationships with circulating endothelial progenitor cells and hypertension. Journal of Human Hypertension, 21, 445–451.
Scranton, R. E., Young, M., Lawler, E., Solomon, D., Gagnon, D., & Gaziano, J. M. (2005). Statin use and fracture risk: Study of a US veterans population. Archives of Internal Medicine, 165, 2007–2012.
Tan, K. C., Wat, N. M., Tam, S. C., Janus, E. D., Lam, T. H., & Lam, K. S. (2003). C-reactive protein predicts the deterioration of glycemia in Chinese subjects with impaired glucose tolerance. Diabetes Care, 26, 2323–2328.
Debray, F. G., Mitchell, G. A., Allard, P., Robinson, B. H., Hanley, J. A., & Lambert, M. (2007). Diagnostic accuracy of blood lactate-to-pyruvate molar ratio in the differential diagnosis of congenital lactic acidosis. Clinical Chemistry, 53, 916–921.
Ip, M. S., Tse, H. F., Lam, B., Tsang, K. W., & Lam, W. K. (2004). Endothelial function in obstructive sleep apnea and response to treatment. American Journal of Respiratory and Critical Care Medicine, 169, 348–353.
Lamperti, C., Naini, A. B., Lucchini, V., Prelle, A., Bresolin, N., Moggio, M., et al. (2005). Muscle coenzyme Q10 level in statin-related myopathy. Archives of Neurology, 62, 1709–1712.
Gutierrez, J., Ballinger, S. W., Darley-Usmar, V. M., & Landar, A. (2006). Free radicals, mitochondria, and oxidized lipids: The emerging role in signal transduction in vascular cells. Circulation Research, 99, 924–932.
Nishikawa, T., Edelstein, D., Du, X. L., Yamagishi, S., Matsumura, T., Kaneda, Y., et al. (2000). Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature, 404, 787–790.
Knight-Lozano, C. A., Young, C. G., Burow, D. L., Hu, Z. Y., Uyeminami, D., Pinkerton, K. E., et al. (2002). Cigarette smoke exposure and hypercholesterolemia increase mitochondrial damage in cardiovascular tissues. Circulation, 105, 849–854.
Kavanagh, T., Mertens, D. J., Hamm, L. F., Beyene, J., Kennedy, J., Corey, P., et al. (2003). Peak oxygen intake and cardiac mortality in women referred for cardiac rehabilitation. Journal of the American College of Cardiology, 42, 2139–2143.
Myers, J., Prakash, M., Froelicher, V., Do, D., Partington, S., & Atwood, J. E. (2002). Exercise capacity and mortality among men referred for exercise testing. New England Journal of Medicine, 346, 793–801.
Csiszar, A., Labinskyy, N., Orosz, Z., & Ungvari, Z. (2006). Altered mitochondrial energy metabolism may play a role in vascular aging. Medical Hypotheses, 67, 904–908.
Lee, J. Y., Jung, G. Y., Heo, H. J., Yun, M. R., Park, J. Y., Bae, S. S., et al. (2006). 4-Hydroxynonenal induces vascular smooth muscle cell apoptosis through mitochondrial generation of reactive oxygen species. Toxicology Letters, 166, 212–221.
Kinscherf, R., Deigner, H. P., Usinger, C., Pill, J., Wagner, M., Kamencic, H., et al. (1997). Induction of mitochondrial manganese superoxide dismutase in macrophages by oxidized LDL: Its relevance in atherosclerosis of humans and heritable hyperlipidemic rabbits. FASEB J, 11, 1317–1328.
Van Etten, R. W., de Koning, E. J., Honing, M. L., Stroes, E. S., Gaillard, C. A., & Rabelink, T. J. (2002). Intensive lipid lowering by statin therapy does not improve vasoreactivity in patients with type 2 diabetes. Arteriosclerosis, Thrombosis, and Vascular Biology, 22, 799–804.
Ridker, P. M., Danielson, E., Fonseca, F. A., Genest, J., Gotto, A. M., Jr., Kastelein, J. J., et al. (2009). Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: A prospective study of the JUPITER trial. Lancet, 373, 1175–1182.
Wenzel, P., Schuhmacher, S., Kienhofer, J., Muller, J., Hortmann, M., Oelze, M., et al. (2008). Manganese superoxide dismutase and aldehyde dehydrogenase deficiency increase mitochondrial oxidative stress and aggravate age-dependent vascular dysfunction. Cardiovascular Research, 80, 280–289.
Yufu, K., Takahashi, N., Hara, M., Saikawa, T., & Yoshimatsu, H. (2007). Measurement of the brachial-ankle pulse wave velocity and flow-mediated dilatation in young, healthy smokers. Hypertension Research, 30, 607–612.
Acknowledgments
This study was supported by the CRCG Small Project Funding of University of Hong Kong (Project No. 200907176063) and Sun Chieh Yeh Heart Foundation.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Dai, YL., Luk, TH., Siu, CW. et al. Mitochondrial Dysfunction Induced by Statin Contributes to Endothelial Dysfunction in Patients with Coronary Artery Disease. Cardiovasc Toxicol 10, 130–138 (2010). https://doi.org/10.1007/s12012-010-9071-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12012-010-9071-1